Patent · US Active

Stable solid forms of regadenoson

US10144756B2 · kind B2 · utility

0Cited by
1References
23Claims
0Family size

Inventors

Key dates

Filing dateOct 7, 2015
Grant dateDec 4, 2018
Priority date
Expiry dateMay 14, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/13
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A process for the preparation of the amorphous form of Regadenoson of formula is disclosed together with new crystalline polymorphic forms E, F and G and methods for their preparation. Regadenoson amorphous form can be prepared in mild reaction conditions with high chemical purity (>99.6%) and high stability to the heating. A particularly thermodynamically stable anhydrous crystalline form of Regadenoson (form G) is also disclosed, provided with high stability not when exposed to 90% RH at 25° C. for 96 hour, but also to the heating up to 200° C.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.